Aspergillus--classification and antifungal susceptibilities

Curr Pharm Des. 2013;19(20):3615-28. doi: 10.2174/1381612811319200005.

Abstract

Aspergillus is one of the most important fungal genera for the man, for its industrial use, its ability to spoil food and not least its medical impact as cause of a variety of diseases. Currently hundreds of species of Aspergillus are known; nearly fifty of them are able to cause infections in humans and animals. Recently, the genus Aspergillus is subdivided into 8 subgenera and 22 sections. The spectrum of diseases caused by Aspergillus species varies from superficial cutaneous to invasive and systemic infections. All species of Aspergillus investigated so far are resistant against the antifungals fluconazole and 5-fluorocytosine, the range of susceptibilities to currently available antifungals is discussed in this paper.

Publication types

  • Review

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Aspergillosis / drug therapy*
  • Aspergillosis / epidemiology
  • Aspergillosis / microbiology
  • Aspergillus / classification
  • Aspergillus / drug effects*
  • Aspergillus / isolation & purification
  • Drug Resistance, Fungal
  • Fluconazole / pharmacology
  • Flucytosine / pharmacology
  • Humans

Substances

  • Antifungal Agents
  • Fluconazole
  • Flucytosine